| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.30▼ | 8.28▲ | 8.27▲ | 8.55▼ | 8.73▼ |
| MA10 | 8.27▲ | 8.26▲ | 8.30▼ | 8.62▼ | 7.99▲ |
| MA20 | 8.25▲ | 8.33▼ | 8.42▼ | 8.78▼ | 8.58▼ |
| MA50 | 8.35▼ | 8.54▼ | 8.58▼ | 8.02▲ | 7.24▲ |
| MA100 | 8.46▼ | 8.82▼ | 8.79▼ | 8.54▼ | 11.34▼ |
| MA200 | 8.83▼ | 8.32▼ | 7.97▲ | 8.19▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | 0.012▲ | -0.005▼ | -0.107▼ | 0.067▲ |
| RSI | 49.396▼ | 43.931▼ | 42.604▼ | 50.004▲ | 50.881▲ |
| STOCH | 79.167 | 68.978 | 21.504 | 36.893 | 55.250 |
| WILL %R | -25.000▲ | -57.627 | -77.679▼ | -70.455 | -53.161 |
| CCI | 78.513 | 31.159 | -35.293 | -86.807 | 32.629 |
|
Wednesday, December 10, 2025 05:41 AM
However, When quite a few insiders buy shares, as it happened in CervoMed Inc.'s (NASDAQ:CRVO) case, it's fantastic news for shareholders. Although we don't think shareholders should simply follow ...
|
|
Thursday, December 04, 2025 02:12 PM
Key findings showed neflamapimod reduced clinical worsening by 52% on the primary endpoint, Clinical Dementia Rating Sum of Boxes (CDR-SB), compared to control at 16 weeks. This effect was even more ...
|
|
Monday, November 17, 2025 03:47 AM
The average one-year price target for CervoMed (NasdaqCM:CRVO) has been revised to $22.88 / share. This is an increase of 13.77% from the prior estimate of $20.11 dated November 7, 2025. The price ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 8.16 | 8.45 | 8.15 | 8.45 | 15,779 |
| 11/12/25 | 8.57 | 8.68 | 8.13 | 8.19 | 35,809 |
| 10/12/25 | 8.57 | 8.85 | 8.3012 | 8.67 | 45,474 |
| 09/12/25 | 8.82 | 8.85 | 8.545 | 8.63 | 21,369 |
| 08/12/25 | 8.69 | 8.93 | 8.6201 | 8.79 | 38,226 |
| 05/12/25 | 9.21 | 9.22 | 8.64 | 8.69 | 56,847 |
| 04/12/25 | 8.15 | 9.06 | 8.15 | 9.06 | 51,769 |
| 03/12/25 | 8.21 | 8.54 | 7.80 | 8.28 | 87,261 |
| 02/12/25 | 9.32 | 9.465 | 8.0217 | 8.22 | 136,694 |
| 01/12/25 | 9.71 | 9.7904 | 9.17 | 9.22 | 70,795 |
|
|
||||
|
|
||||
|
|